Researcher fighting breast cancer with light therapy
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.
Oct 17, 2018
0
14
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.
Oct 17, 2018
0
14
Effective hearing loss treatments have eluded medicine because once sensory cells in the inner ear called hair cells are damaged or destroyed, they cannot be regenerated. This loss of hair cells, which can be caused by aging, ...
Apr 18, 2023
2
71
A Rice University chemist's research conducted years ago to protect people from radiation poisoning due to nuclear fallout may now offer a glimmer of hope to patients with pancreatic cancer.
Apr 5, 2019
0
111
For the first time, a drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very low levels of the protein.
Jun 5, 2022
0
32
Many cancer patients, especially those who've undergone breast cancer treatment, experience painful, swollen limbs, a condition called lymphedema.
May 10, 2017
0
69
An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National ...
Nov 21, 2013
0
0
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.
Aug 26, 2015
0
107
A preclinical study conducted at the Institute of Oncology Research (IOR, affiliated to USI Università dellaSvizzera italiana) reveals the role of aging cells in the formation of metastases and identifies a drug capable ...
Nov 13, 2020
0
122
Overshadowed by the global push for vaccines, the search for treatments for COVID-19 has made steady—if slower—progress.
Sep 27, 2021
0
31
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed ...
Jun 4, 2021
0
41